Abstract
Process research, development, and manufacture of TP-808 (1), a key intermediate for the discovery and manufacture of tetracycline analogues, is described. The process used for the preparation of 1 avoids chromatographic purifications and has been substantially improved over the previously reported preparation. The robustness of the process was demonstrated in a 76.1 kg manufacturing campaign with 56% overall yield.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have